Table 3.
Dietary intakes in cystic fibrosis (CF) patients and healthy subjects (HS).
| Parameters | CF Patients | HS | p |
|---|---|---|---|
| Median (1st–3rd Quartile) | |||
| N | 45 | 35 | — |
| Energy [kcal/d] | 2433 (2114–2699) |
1850 (1730–2245) |
0.0005 |
| EER [%] | 121.5 (96.8–130.5) |
94.4 (86.6–101.2) |
0.0004 |
| Total fat [% en] | 37.3 (33.5–40.5) |
39.1 (33.9–45.0) |
ns. |
| Total fat [g/d] | 102.2 (86.4–119.5) |
84.3 (71.3–107.5) |
0.0273 |
| Cholesterol [mg/d] | 332.4 (244.6–435.0) |
288.2 (149.1–315.3) |
0.0132 |
| Total phytosterol [mg/d] | 125.2 (101.5–198.8) |
151.3 (131.1–214.8) |
ns. |
| Campesterol [mg/d] | 28.5 (22.6–44.6) |
33.7 (25.6–48.8) |
ns. |
| Β-sitosterol [mg/d] | 72.2 (57.1–112.5) |
88.8 (70.9–145.1) |
ns. |
| Stigmasterol [mg/d] | 3.1 (1.8–4.5) |
4.0 (3.0–6.9) |
ns. |
| Lipase dose * [U/g of fat] |
2060 (1540–3042) |
— | — |
EER—estimated energy requirement. *—for pancreatic-insufficient patients.